Evolent Health: Oppenheimer raises target price to $7 from $6
EVH•Oppenheimer raised its target price for Evolent Health to $7 from $6.
Related News
OneMedNet forecasts fourth-quarter 2026 revenue of $12 million to $14 million
ONMD•
Shift4 Payments: B. Riley cuts target price to $77 from $94
FOUR•
Soligenix announces recent updates and third-quarter 2026 financial results
SNGX•
JPMorgan cuts Akamai Technologies target price to $120 from $167
AKAM•
US job growth beats expectations in October; unemployment rate falls to 4.1%
SPY•